EQS-News: Douglas GmbH / Key word(s): Bond Douglas GmbH: DOUGLAS will pay interest on PIK notes in cash 16.10.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. IR NEWS Cash payment of interest on Kirk Beauty SUN notes on the back of strong cash generation DOUGLAS will pay interest on PIK notes in cash
Düsseldorf, 16 October 2023 – DOUGLAS, Europe’s leading omnichannel beauty destination, will start to pay cash interest on its Kirk Beauty SUN notes starting with the payment date 16 October 2023. This shift has two positive effects for DOUGLAS: first, the gross debt will not increase any further which supports DOUGLAS on its deleveraging path. Second, the cash interest rate is at 8.25% and thereby 75 basis points lower than PIK interest rate which represents interest cost savings of more than 4 million Euro per year in addition to the ceasing compound effect from PIK interest. “Our third quarter results already showed the strong cash generation of DOUGLAS even in a still challenging economic environment”, said Mark Langer. “With this switch to cash interest payment we underline our ambition to deleverage DOUGLAS not only by growing our EBITDA, but also by keeping the gross debt stable.” The cash interest was paid today, the next payment date is 15 April 2024. ABOUT DOUGLAS DOUGLAS is Europe’s leading omnichannel beauty destination. We inspire customers to live their own kind of beauty by offering a unique assortment in online stores, via a partner program and in around 1,840 stores. Strengthening our successful omnichannel positioning while consistently developing the customer experience is at the heart of our strategy. In its fiscal year 2021/22, DOUGLAS generated sales of 3.65 billion euros with a focus on fragrances, make-up, skin care, hair care, health care and accessories. INVESTOR RELATIONS CONTACT Stefanie Steiner Head of Investor Relations and M&A Phone: +49 (0)211 16847 8594 E-mail: ir@douglas.de 16.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Takeda withdraws application for dengue vaccine from FDA
Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or